Results

Total Results: 1,598 records

Showing results for "reasons".

101. Bar-Cohen_ ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/bar-cohen_-eccs2012.pdf
     January 01, 2012 - Bar-Cohen_ ECCS2012 Slide 1: Addressing  Tensions  When Social/Family Support and Evidence-­‐ Based Care Collide Annette Bar-­‐Cohen, M.A., M.P.H., Discussant Executive Director, Center for NBCC Advocacy Training National Breast Cancer  Coalition,  Washington,  DC …

102. White Paper_Living Systematic Reviews: Examining Excluded Full-Text Articles To Better Understand the Evidence Base on Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/living-systematic-reviews-full-text-articles-white-paper.pdf
     January 01, 2024 - The most frequent reasons for exclusion of articles at the full- text review stage were study designs … Excluded Studies With Detailed Reasons 1 1. … Excluded Studies With Detailed Reasons Table A-1. … Excluded studies with detailed reasons Author Year Title Exclusion Code Detailed Exclusion Reason … Excluded Studies With Detailed Reasons

103. • Identify disparities and reasons for disparities and reevaluate the framework for researching disparities The following article was used in answering this question: Davis, L. M., Kilburn, M. R., and Schultz, D. (2009). Reparable Harm:… | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/identify-disparities-and-reasons-for-disparities-and-reevaluate-the-framework-for-researching-disparities-the-following-article-was-used-in-answering-this-question-davis-l-m-kilburn-m-r-and-schultz-d-2009-reparable-harm-asse

104. Adverse Events Associated with COVID-19 Pharmaceutical Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments.pdf
     December 23, 2023 - We will maintain a record of studies excluded at the full-text level with reasons for exclusion. … The assessment will clearly document uncertainty, outline the reasons for insufficient evidence where

105. Using Deliberative Methods to Engage Patients, Consumers, and the Public (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/deliberative-methods_presentation-2011.pdf
     January 01, 2011 - Using Deliberative Methods to Engage Patients, Consumers, and the Public Community Forum Community Forum Agency for Healthcare Research and Quality Community Forum December 6, 2011 Using Deliberative Methods to Engage Patients, Consumers, and the Public Community Forum Community Forum Community …

106. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/questions-what-are-the-appropriate-indications-for-tonsillectomy-recurrent-infections-how-many-sleep-disordered-breathingshould-clinicians-administer-or-prescribe-perioperative-antibiotics-to-children-undergoing-tonsillectomy
     August 20, 2014 - initial hospital stay and up to 3.9 have secondary complications requiring readmission.23 The primary reasons

107. Disposition of Comments Report for Evaluation and Treatment of Cryptorchidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_disposition-comments.pdf
     December 11, 2012 - It is very likely therefore, that one of the reasons for many of the studies reported in this review

108. Breast Reconstruction After Mastectomy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/breast-reconstruction-mastectomy/protocol
     June 18, 2020 - mastectomy Exclude: Studies where ≥10% of women underwent breast reconstruction (combined across reasons … mastectomy Exclude: Studies where ≥10% of women underwent breast reconstruction (combined across reasons … mastectomy Exclude: Studies where ≥10% of women underwent breast reconstruction (combined across reasons … mastectomy Exclude: Studies where ≥10% of women underwent breast reconstruction (combined across reasons … mastectomy Exclude: Studies where ≥10% of women underwent breast reconstruction (combined across reasons

109. Research Protocol: Breast Reconstruction After Mastectomy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-reconstruction-mastectomy-protocol.pdf
     April 09, 2020 - mastectomy • Exclude: Studies where ≥10% of women underwent breast reconstruction (combined across reasons … mastectomy • Exclude: Studies where ≥10% of women underwent breast reconstruction (combined across reasons … mastectomy • Exclude: Studies where ≥10% of women underwent breast reconstruction (combined across reasons … mastectomy • Exclude: Studies where ≥10% of women underwent breast reconstruction (combined across reasons … mastectomy • Exclude: Studies where ≥10% of women underwent breast reconstruction (combined across reasons

110. Ventricular Arrhythmias and Cerebrovascular Events in the Elderly Using Conventional and Atypical Antipsychotic Medications | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antipsychotic-medicine-cardiovascular-elderly/research
     March 18, 2009 - swallowing problems, are all more common with conventional than atypical agents. 5-8 , 12 For these reasons … Reasons for using both drug groups (e.g., dementia, delirium) may themselves be risk factors for these … also restricted analyses to only APM users as well as to just new users, to control for underlying reasons

111. Discontinuation of Disease-Modifying Treatment for Multiple Sclerosis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/multiple-sclerosis/research-protocol
     December 17, 2013 - of discontinuing disease-modifying treatment by examining the long-term benefits and harms, and the reasons … What reasons for discontinuation of disease-modifying treatments have been reported in long-term observational … demographics; type of CIS or MS, MS severity; descriptions and results of outcomes and adverse effects; reasons … Studies will also be grouped by length of followup to examine changes over time, if any, in outcomes and reasons

112. MS Protocol draft_12_12-13 clean[2] (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/multiple-sclerosis_research-protocol.pdf
     December 17, 2013 - of discontinuing disease- modifying treatment by examining the long-term benefits and harms, and the reasons … What reasons for discontinuation of disease-modifying treatments have been reported in long-term observational … demographics; type of CIS or MS, MS severity; descriptions and results of outcomes and adverse effects; reasons … Studies will also be grouped by length of followup to examine changes over time, if any, in outcomes and reasons

113. Disposition of Comments Report for Evaluation and Treatment of Tinnitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_disposition-comments.pdf
     August 23, 2013 - The reasons for exclusion (comparators do not meet criteria, insufficient detail for data aggregation … Sources of funding and investigator conflicts of interest were not reasons for exclusion, nor were … The primary reasons they were excluded is that the studies did not present a measure of variance around … This is one of the reasons why we use meta-analysis. … One of the primary reasons to not undertake meta-analysis are concerns with clinical heterogeneity.

114. Disposition of Comments: Management of Colonic Diverticulitis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diverticulitis-comments.pdf
     October 12, 2020 - under the main points and key points under each key question, it would be helpful to briefly note the reasons … We have added reasons for insufficient evidence for all key/main points.

115. Genitourinary Syndrome of Menopause (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/genitourinary-symptoms-protocol.pdf
     January 30, 2023 - hormonal therapy, with one or more symptom of GSM Individuals with genitourinary symptoms for reasons … a uterus using hormonal therapy primarily for GSM symptoms Patients using hormonal therapy for reasons … Assess different durations of follow-up Menopausal hormone therapy only for reasons other than GSM … 100%: considerable heterogeneity When we find heterogeneity, we will attempt to determine possible reasons

116. CER 174 Executive Summary: Imaging for the Pretreatment of Small Cell Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/lung-cancer-staging_executive.pdf
     April 01, 2016 - The most common reasons for exclusion were: studies of other conditions (e.g., non-small cell lung … The most common reasons were: studies with fewer than 10 SCLC patients and studies of other conditions … Reasons for the moderate rating varied across studies, but common problems included failure to account … The most common reasons for exclusion were studies of other conditions (e.g., non-small- cell lung cancer … Each gap should be assigned one of the following reasons for the inability to draw conclusions: a.

117. Data Points #16: Changes across time and geography in the use of prostate radiation technologies for newly diagnosed older cancer patients: 2006-2008 | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/prostate-cancer-radiation/research
     November 30, 2012 - Therefore, the combination of higher doses permitted with IMRT and lower rectal toxicity are potential reasons

118. Cer-238-Cervical-Ripening-Appendix-E-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-1.xlsx
     January 01, 2009 - excluded) GBS colonization positive: 13.86% Diabetes: -Preexisting: NR -Gestational: 9.90% (listed as reasons

119. Disposition of Comments Report for Comparative Effectiveness Review 128 Oral Mechanical Bowel Preparation for Colorectal Surgery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_disposition-comments.pdf
     April 30, 2014 - Peer Reviewer #1 Methods The search strategies are well detailed and well designed, and the reasons … The fact that a group of studies was not deemed within the scope of the report (for feasibility reasons … vs. left colon vs. rectum) or surgical approach (laparoscopic versus open) are clinically important reasons … This is one of the reasons we did not synthesize studies comparing alternative active OMBP strategies … This is one of the reasons we did not synthesize studies comparing alternative active OMBP strategies

120. Disposition of Comments Report for CER 203 ADHD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-203-adhd-disposition-comments.pdf
     January 01, 2018 - TEP Reviewer #2 General [abstract] Would be helpful to explain reasons for not including all available … None of the tables in the review indicate the specific reasons why a study was assigned a particular … We acknowledge that we do not provide reasons for exclusion at the title/abstract screening level beyond … documenting the number of citations excluded at that stage; to provide reasons for exclusion of all … For those reasons, I do not believe that the tables are up to the current standards of meta- analytic